Society for Biological Therapy. Annual meetingJournal of immunotherapy. 1994, Vol 16, Num 3, pp 234-249, issn 1053-8550Conference Proceedings

Society for Biological Therapy. Annual meetingJournal of immunotherapy. 1993, Vol 14, Num 4, pp 357-369, issn 1053-8550Conference Proceedings

Society for Biological Therapy. Annual meetingJournal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 127-137, issn 1067-5582Conference Proceedings

A genetic approach to idiotypic vaccinationHAWKINS, R. E; WINTER, G; HAMBLIN, T. J et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 273-278, issn 1053-8550Conference Paper

Cerebral vasculitis after interleukin-2 therapy for renal cell carcinomaMICHEL, M; VINCENT, F; SIGAL, R et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 124-126, issn 1067-5582Conference Paper

Possible myocardial toxicity associated with interleukin-4 therapyTREHU, E. G; ISNER, J. M; MIER, J. W et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 348-351, issn 1053-8550Conference Paper

Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2MCADAM, A. J; KUN-YUN YEH; PULASKI, B. A et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 293-297, issn 1053-8550Conference Paper

Heat shock protein vaccines against cancerBLACHERE, N. E; UDONO, H; JANETZKI, S et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 352-356, issn 1053-8550Conference Paper

Cytokine-induced tumor immunogenicity : from exogenous cytokines to gene therapyFORNI, G; GIOVARELLI, M; CAVALLO, F et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 253-257, issn 1053-8550Conference Paper

Liposome-encapsulated MTP-PE : a novel biologic agent of cancer therapyASANO, T; KLEINERMAN, E. S.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 286-292, issn 1053-8550Conference Paper

Influence of biological response modifiers : measurement of tumor blood flow and temperatureLI, J; MERTON, D. A; THAKUR, M. L et al.Journal of immunotherapy. 1994, Vol 16, Num 3, pp 175-180, issn 1053-8550Conference Paper

Preclinical evaluation in nonhuman primates of an anti-idiotypic antibody that mimicks the carcinoembryonic antigenMALA CHAKRABROTY; FOON, K. A; KOHLER, H et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 95-103, issn 1067-5582Conference Paper

Activation of multiple effector mechanisms to enhance tumor immunotherapyHANK, J. A; ALBERTINI, M. R; SCHILLER, J et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 329-335, issn 1053-8550Conference Paper

Cytokine gene transfer as a therapeutic strategyPATEL, P. M; FLEMMING, C. L; RUSSELL, S. J et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 310-313, issn 1053-8550Conference Paper

Recombinant vaccinia interleukin-2-infected tumor cell vaccines in immunotherapy of murine colon adenocarcinomaBASH, J. A.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 269-272, issn 1053-8550Conference Paper

Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcomaMOMIN, F. A; ZALUPSKI, M; HEILBURN, L. K et al.Journal of immunotherapy. 1994, Vol 16, Num 3, pp 224-228, issn 1053-8550Conference Paper

Phase II trial of recombinant interleukin-1β in patients with metastatic renal cell carcinomaREDMAN, B. G; YOUSIF ABUBAKR; TA-HSU CHOU et al.Journal of immunotherapy. 1994, Vol 16, Num 3, pp 211-215, issn 1053-8550Conference Paper

In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagentsSUYU SHU; SUSSMAN, J. J; CHANG, A. E et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 279-285, issn 1053-8550Conference Paper

Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4KAWAKAMI, Y; HAAS, G. P; LOTZE, M. T et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 336-347, issn 1053-8550Conference Paper

Severe reversible global and regional ventricular dysfunction associated with high-dose interleukin-2 immunotherapyDU BOIS, J. S; UDELSON, J. E; ATKINS, M. B et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 119-123, issn 1067-5582Conference Paper

Transfer and expression of the human interleukin-4 gene in carcinoma and stromal cell lines derived from lung cancer patientsHUNT, J. D; PIPPIN, B. A; LANDRENEAU, R. J et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 314-321, issn 1053-8550Conference Paper

A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma : a Southwest Oncology Group StudyWHITEHEAD, R. P; WOLF, M. K; SOLANKI, D. L et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 104-114, issn 1067-5582Conference Paper

Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantationFALKENBURG, J. H. F; FABER, L. M; VAN DEN ELSHOUT, M et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 305-309, issn 1053-8550Conference Paper

Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4LINDGREN, C. G; THOMPSON, J. A; HIGUCHI, C. M et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 322-328, issn 1053-8550Conference Paper

Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumorOSSEVOORT, M. A; FELTKAMP, M. C. W; VAN VEEN, K. J. H et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 86-94, issn 1067-5582Conference Paper